Semaglutide
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
Novo Nordisk · Phase 3 · Completed · Enrollment 408
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| TQF3510 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Wegovy® | Obesity or overweight | n/r | n/r | n/r | n/r |